HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kentarou Kudou Selected Research
Kentarou Kudou Research Topics
Disease
5
Menorrhagia
10/2021 - 01/2019
3
Leiomyoma (Uterine Fibroids)
10/2021 - 01/2019
3
Pain (Aches)
01/2021 - 11/2019
3
Metrorrhagia (Spotting)
01/2021 - 11/2019
3
Hypertriglyceridemia
12/2015 - 05/2013
2
Pelvic Pain
01/2021 - 01/2021
2
Endometriosis
01/2021 - 01/2021
1
Duodenal Ulcer (Curling's Ulcer)
07/2022
1
Gastroparesis
01/2022
1
Menstruation Disturbances
01/2021
1
Hyperhidrosis
11/2019
1
Respiratory Tract Infections (Respiratory Tract Infection)
11/2019
1
Myoma
01/2019
1
Hemorrhage
01/2019
1
Heartburn (Pyrosis)
04/2018
1
Esophagitis
04/2018
1
Prostatic Neoplasms (Prostate Cancer)
12/2015
1
Cardiovascular Diseases (Cardiovascular Disease)
05/2013
1
Dyslipidemias (Dyslipidemia)
05/2013
Drug/Important Bio-Agent (IBA)
5
relugolix
IBA
10/2021 - 01/2019
4
Gonadotropin-Releasing Hormone (GnRH)
FDA Link
10/2021 - 01/2019
4
LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)
IBA
10/2021 - 11/2019
4
Leuprolide (Lupron)
FDA Link
Generic
01/2021 - 12/2015
3
TAK-085
IBA
12/2015 - 05/2013
2
Lansoprazole (Prevacid)
FDA Link
Generic
07/2022 - 04/2018
2
Pharmaceutical Preparations
IBA
07/2022 - 11/2019
2
1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamine
IBA
07/2022 - 04/2018
2
Acetates (Acetic Acid Esters)
FDA Link
01/2019 - 12/2015
2
Eicosapentaenoic Acid
IBA
12/2015 - 05/2013
2
4,7,10,13,16,19-docosahexaenoic acid ethyl ester
IBA
11/2013 - 05/2013
2
eicosapentaenoic acid ethyl ester
IBA
11/2013 - 05/2013
2
Omega-3 Fatty Acids (Omega 3 Fatty Acids)
IBA
11/2013 - 05/2013
2
Triglycerides (Triacylglycerol)
IBA
11/2013 - 05/2013
1
trazpiroben
IBA
01/2022
1
Dopamine (Intropin)
FDA Link
Generic
01/2022
1
Hemoglobins (Hemoglobin)
IBA
01/2019
1
Acids
IBA
04/2018
1
LDL Cholesterol
IBA
12/2015
1
LDL Lipoproteins (beta Lipoproteins)
IBA
12/2015
1
Esters
IBA
12/2015
1
Apolipoproteins
IBA
12/2015
1
oxidized low density lipoprotein
IBA
12/2015
1
polyacrylamide
IBA
12/2015
1
Lipids
IBA
11/2013
Therapy/Procedure
2
Therapeutics
01/2022 - 04/2018
1
Oral Administration
01/2021
1
Injections
01/2019
1
Aftercare (After-Treatment)
01/2019